Loading…
Loading…
CYP2D6 predicted metabolizer status and safety in adult patients with attention-deficit hyperactivity disorder participating in a large placebo-controlled atomoxetine maintenance of response clinical trial
Fijal, Bonnie A, Guo, Yingying, Li, Si G, Ahl, Jonna, Goto, Taro, Tanaka, Yoko, Nisenbaum, Laura K, Upadhyaya, Himanshu P
Published in Journal of clinical pharmacology (01.10.2015)
Published in Journal of clinical pharmacology (01.10.2015)
Get more information
Journal Article
Loading…
Sex Differences in the Effect of Atomoxetine on the QT Interval in Adult Patients With Attention-Deficit Hyperactivity Disorder
Suzuki, Yutaro, Tajiri, Misuzu, Sugimoto, Atsunori, Orime, Naoki, Hayashi, Taketsugu, Egawa, Jun, Sugai, Takuro, Inoue, Yoshimasa, Someya, Toshiyuki
Published in Journal of clinical psychopharmacology (01.02.2017)
Published in Journal of clinical psychopharmacology (01.02.2017)
Get more information
Journal Article
Loading…
Osmotic Release Oral System Methylphenidate Versus Atomoxetine for the Treatment of Attention-Deficit/Hyperactivity Disorder in Chinese Youth: 8-Week Comparative Efficacy and 1-Year Follow-Up
Su, Yi, Yang, Li, Stein, Mark A., Cao, Qingjiu, Wang, Yufeng
Published in Journal of child and adolescent psychopharmacology (01.05.2016)
Published in Journal of child and adolescent psychopharmacology (01.05.2016)
Get full text
Journal Article